NCT06142487

Brief Summary

The purpose of this study is to determine the effects of using silk pillowcases in mild to moderate non-cystic acne prone skin in comparison to cotton pillowcases.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2023

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 13, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 21, 2023

Completed
Last Updated

November 21, 2023

Status Verified

November 1, 2023

Enrollment Period

Same day

First QC Date

November 13, 2023

Last Update Submit

November 16, 2023

Conditions

Keywords

acnenon-cystic acnemild to moderate acne

Outcome Measures

Primary Outcomes (3)

  • Acne Lesion Counts: Inflammatory Lesions

    The inflammatory lesion counts will be counted and compared against baseline

    8 weeks

  • Acne Lesion Counts: Non-Inflammatory Lesions

    The non-inflammatory lesion counts will be counted and compared against baseline

    8 weeks

  • Facial Erythema Intensity Score

    Facial erythema will be measured as the erythema intensity score as measured by the image analysis system (BTBP 3D Pro)

    8 Weeks

Secondary Outcomes (4)

  • Transepidermal water loss

    8 Weeks

  • Sebum Excretion Rate

    8 weeks

  • Skin Microbiome, relative abundance of C. acnes

    8 Weeks

  • Skin Hydration

    8 Weeks

Study Arms (2)

Silk Pillowcase

EXPERIMENTAL

100% Mulberry Silk Pillowcase used every night

Other: Silk Pillowcase

Cotton Pillowcase

ACTIVE COMPARATOR

100% Cotton Pillowcase used every night

Other: Cotton Pillowcase

Interventions

100% Mulberry Silk Pillowcase

Silk Pillowcase

100% Cotton Pillowcase

Cotton Pillowcase

Eligibility Criteria

Age15 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Males and females between the ages of 15-45 years of age
  • The presence of mild to moderate acne vulgaris based on investigator global assessment
  • Presence of at least 5 inflammatory lesions and at least 5 non-inflammatory lesions

You may not qualify if:

  • The presence of severe acne as noted by investigator global assessment.
  • Those who are unwilling to discontinue systemic antibiotics and benzoyl peroxide for 4 weeks meet the washout criteria prior to enrolling.
  • Those who are unwilling to keep their facial regimen consistent throughout the study, and for 1 month prior to enrolling.
  • Individuals who are unwilling to wash pillowcase every week using provided detergent.
  • Use of isotretinoin within the three months prior to enrolment
  • Individuals who primarily sleep on their back
  • Current tobacco smoker or a tobacco smoking history of greater than 10 pack year
  • Individuals on oral contraceptive pills or progesterone or estrogen containing therapies.
  • Individuals who have changed any of their hormonal based contraception within 3 months prior to joining the study
  • Individuals with known allergy or sensitivity to Mulberry Silk or Cotton Fibers in fabric

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acne Vulgaris

Condition Hierarchy (Ancestors)

Acneiform EruptionsSkin DiseasesSkin and Connective Tissue DiseasesSebaceous Gland Diseases

Study Officials

  • Raja K Sivamani, MD MS AP

    Study Principal Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

November 13, 2023

First Posted

November 21, 2023

Study Start

November 10, 2023

Primary Completion

November 10, 2023

Study Completion

November 10, 2023

Last Updated

November 21, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share